Reproducibility of sentinel node detection in endometrial cancer by ICG fundic & cervical injection

Objective: The aim of this study is to study the reproducibility of the dual injection technique of IndoCyanine Green (ICG) in the cervix and fundus in endometrial cancer. Methods: Between June 2014, and December 2019, 278 patients underwent laparoscopic surgery for endometrial cancer at our institution. In all cases, under a prospective cohort study, we performed Sentinel Lymph Node (SLN) biopsy with dual cervical and fundal ICG injection. Lymphadenectomy was also performed if intermediate or high-risk criteria were present. All cases were performed independently by three surgeons, with the same protocol and system, and their results were compared. Results: Global, aortic, pelvic and bilateral pelvic detection rates (DRs) were 93.45%, 67.27%, 90.18% and 67.64%. There were no significant differences for DRs between the three surgeons. The probability of finding a positive SLN was 8.8% (SD 2.8), 21% (SD 4.1) and 12% (SD 3.3), respectively, with a significant chi-squared difference (p = 0.041), which was statistically associated with preoperative risk factors (p < 0.001) and not to a surgeon’s factor in a multivariate logistic regression. Conclusions: The SLN biopsy with both cervical and fundal ICG injection offers good overall detection rates and improved mapping of the aortic area and can be reproduced with similar results among different surgeons.

Sentinel node; Endometrial cancer; Indocyanine green; Lymphadenectomy; Reproducibility; Aortic sentinel node

[1] Khoury-Collado F, St Clair C, Abu-Rustum NR. Sentinel Lymph Node Mapping in Endometrial Cancer: an Update. The Oncologist. 2016; 21: 461–466.

[2] Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. The Lancet Oncology. 2017; 18: 384–392.

[3] Amant F, Trum H. Sentinel-lymph-node mapping in endometrial cancer: routine practice? The Lancet Oncology. 2017; 18: 281– 282.

[4] Abu-Rustum NR. The increasing credibility of sentinel lymph node mapping in endometrial cancer. Annals of Surgical Oncol- ogy. 2013; 20: 353–354.

[5] Kim CH, Soslow RA, Park KJ, Barber EL, Khoury-Collado F, Bar- lin JN, et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. International Journal of Gynecological Cancer. 2013; 23: 964–970.

[6] Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. International Journal of Gynecologic Cancer. 2020; 31: 12–39.

[7] Khoury-Collado F, Glaser GE, Zivanovic O, Sonoda Y, Levine DA, Chi DS, et al. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? Gynecologic Oncology. 2009; 115: 453–455.

[8] Barlin JN, Khoury-Collado F, Kim CH, Leitao MM, Chi DS, Son- oda Y, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecologic Oncology. 2012; 125: 531–535.

[9] Kim S, Ryu KJ, Min KJ, Lee S, Jung US, Hong JH, et al. Learning curve for sentinel lymph node mapping in gynecologic malignancies. Journal of Surgical Oncology. 2020; 121: 599–604.

[10] Tucker K, Staley S, Gehrig PA, Soper JT, Boggess JF, Ivanova A, et al. Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution. International Journal of Gynecologic Cancer. 2020; 30: 346–351.

[11] Ruiz R, Gorostidi M, Jaunarena I, Goiri C, Aguerre J, Lekuona A. Sentinel Node Biopsy in Endometrial Cancer with Dual Cervical and Fundal Indocyanine Green Injection. International Journal of Gynecologic Cancer. 2018; 28: 139–144.

[12] Eoh KJ, Lee YJ, Kim H, Lee J, Nam EJ, Kim S, et al. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: a novel sentinel lymph node tracer in- jection procedure. Surgical Oncology. 2018; 27: 514–519.

[13] Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. In- ternational Journal of Gynecological Cancer. 2016; 26: 2–30.

[14] Persson J, Geppert B, Lönnerfors C, Bollino M, Måsbäck A. Description of a reproducible anatomically based surgical algorithm for detection of pelvic sentinel lymph nodes in endometrial cancer. Gynecologic Oncology. 2017; 147: 120–125.

[15] Martinelli F, Ditto A, Signorelli M, Bogani G, Chiappa V, Lorusso D, et al. Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: a single center evaluation over 200 cases. Gynecologic Oncology. 2017; 146: 525–530.

[16] Ditto A, Casarin J, Pinelli C, Perrone AM, Scollo P, Martinelli F, et al. Hysteroscopic versus cervical injection for sentinel node detec- tion in endometrial cancer: a multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group. European Journal of Cancer. 2020; 140: 1–10.

[17] Kataoka F, Susumu N, Yamagami W, Kuwahata M, Takigawa A, Nomura H, et al. The importance of para-aortic lymph nodes in sentinel lymph node mapping for endometrial cancer by using hysteroscopic radio-isotope tracer injection combined with subserosal dye injection: Prospective study. Gynecologic Oncology. 2016; 140: 400–404.

[18] Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. European Journal of Gynaecological Oncology. 2002; 23: 53–57.

[19] Kang S, Yoo HJ, Hwang JH, Lim M, Seo S, Park S. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecologic Oncology. 2011; 123: 522–527.

[20] How JA, O’Farrell P, Amajoud Z, Lau S, Salvador S, How E, et al. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Minerva Obstetrics and Gynecol- ogy. 2018; 70: 194–214.

[21] Capozzi VA, Valentina C, Giulio S, Alessandra C, Giulia G, Giulia A, et al. Sentinel node mapping in endometrial cancer: Tips and tricks to improve bilateral detection rate. the sentitricks study, a monocentric experience. Taiwanese Journal of Obstetrics and Gy- necology. 2021; 60: 31–35.